| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968058 | Vaccine | 2012 | 7 Pages |
Abstract
⺠CSL TIVs, as a class, induce greater cytokines/gene signatures compared to other licensed TIVs. ⺠New H1N1 and B strains in Fluvax 2010 contribute to a further increase in cytokine signal. ⺠Febrile events by paediatric Fluvax 2010 likely due to: ⺠Introduction of new 2010 Influenza strains. ⺠Differences in the manufacturing process as compared to other licensed TIVs.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Eugene Maraskovsky, Steve Rockman, Allison Dyson, Sandra Koernig, Dorit Becher, Adriana Baz Morelli, Megan Barnden, Sarina Camuglia, Jesse Bodle, Kirsten Vandenberg, I-Ming Wang, Razvan Cristescu, Andrey Loboda, Mike Citron, Jane Fontenot, Derchieh Hung,